Početna › Prekomjerna tjelesna masa › Kalifornija
Kliničke studije za Prekomjerna tjelesna masa u državi Kalifornija
64 studija za Prekomjerna tjelesna masa traži sudionike na lokacijama u državi Kalifornija.
Gradovi u državi Kalifornija
- Concord16 studija
- Los Angeles15 studija
- San Diego13 studija
- Escondido12 studija
- El Cajon9 studija
- Torrance9 studija
- Santa Ana7 studija
- Tustin7 studija
- Sacramento6 studija
- Long Beach5 studija
- Santa Clarita5 studija
- Huntington Beach5 studija
- Santa Monica5 studija
- Indio5 studija
- South Gate5 studija
- Lake Forest4 studija
- Westminster4 studija
- Richmond4 studija
- Simi Valley4 studija
- Hawthorne4 studija
- Chula Vista4 studija
- Ontario3 studija
- Riverside3 studija
- West Covina3 studija
- Glendale3 studija
Službeni tekst studije (engleski)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- John Muir Health - Concord /ID# 282469, Concord
- NorCal Medical Research /ID# 283117, Greenbrae
- Velocity Clinical Research - Huntington Park /ID# 282987, Huntington Park
- i još 6
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07752979A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
- ProSciento, INC, Chula Vista
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 70 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07675590Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
- Cedars Sinai Medical Center, Los Angeles
U tijeku regrutacija
Od 21 do 65 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07090005AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- Torrance Clinical Research Institute, Inc., Lomita
- Diablo Clinical Research, Inc., Walnut Creek
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07533175A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Neighborhood Healthcare, Escondido
U tijeku regrutacijaFaza 3
Od 8 do 18 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT07253285Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- Diablo Clinical Research - Flourish Research, Walnut Creek
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07685808Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- Profound Research, Oceanside
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT07837973AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Providence Medical Foundation, Fullerton
- Torrance Clinical Research Institute, Inc., Lomita
- Diablo Clinical Research, Inc., Walnut Creek
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07720271A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- First Valley Medical Group, Lancaster
- Desert Oasis Healthcare, Palm Springs
- Western University of Health Sciences, Pomona
- i još 1
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07668414A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Orange County Research Center, Lake Forest
- Healthy Brain Clinic, Long Beach
- Los Angeles Institute for Metabolic Research, Los Angeles
- i još 6
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07794579A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- San Fernando Valley Health Institute, Canoga Park
- Headlands Research California, LLC, Escondido
- ImmuniMet, LLC, Modesto
- i još 4
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Escondido
- Research Site, Lincoln
- Research Site, Walnut Creek
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07776509Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
- Parexel International, Glendale
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 65 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07594093Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- i još 1
U tijeku regrutacijaFaza 3
Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06937099A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Loma Linda University School of Medicine, Loma Linda
- Childrens Hospital of Los Angeles, Los Angeles
- UCLA Mattel Children's Hospital, Los Angeles
- i još 2
U tijeku regrutacijaFaza 3
Od 6 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06672549Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- i još 1
U tijeku regrutacijaFaza 3
Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06937086A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- San Fernando Valley Health Institute, Canoga Park
- AMCR Institute, Escondido
- NorCal Medical Research, Inc, Greenbrae
- i još 6
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Irvine Clinical Research, Irvine
- Scripps Whittier Diabetes Institute, La Jolla
- EndoTrials Center for Clinical Research, La Mesa
- i još 5
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07392190A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Bakersfield
- Research Site, Gardena
- Research Site, Lincoln
- i još 2
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07784270A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Ark Clinical Research, Long Beach
- Collaborative Neuroscience Research, LLC, Los Alamitos
- Artemis Institute for Clinical Research, Riverside
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07369011CHOICE to AVOID or RESIST
- Cedars-Sinai Medical Center, Beverly Hills
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT06521021Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Valley Clinical Trials, LLC dba Flourish Research, Covina
- Velocity Clinical Research- Huntington Park, Huntington Park
- Orange County Research Center, Lake Forest
- i još 5
U tijeku regrutacijaFaza 3
Od 45 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Neighborhood Healthcare Institute of Health, Escondido
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Desert Oasis Healthcare Medical Group, Palm Springs
- i još 4
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07321886Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Wolverine Clinical Trials, Santa Ana
- Encompass Clinical Research, Spring Valley
- i još 1
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07353931A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- NorCal Medical Research, Inc, Greenbrae
- Velocity Clinical Research, Huntington Park, Huntington Park
- Peninsula Research Associates, Rolling Hills Estates
- i još 1
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07589608A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
- Research Site, Glendale
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 35 do 75 godina · Žene · Ažurirano 17. ruj 2026. · NCT07013643A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Banning
- AURORA-1 Clinical Site, Chula Vista
- AURORA-1 Clinical Site, Covina
- i još 5
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Banning
- AURORA-2 Clinical Site, Chula Vista
- AURORA-2 Clinical Site, Covina
- i još 6
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Orange County Research Center, Lake Forest
- Ark Clinical Research, Long Beach
- Catalina Research Institute, LLC, Montclair
- i još 3
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Wolverine Clinical Trials, Santa Ana
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT06897475A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- University of California Irvine, Irvine
- Artemis Institute for Clinical Research, LLC, San Diego
- Diablo Clinical Research, Inc., Walnut Creek
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07351045AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Artemis Insitute for Clin Res, San Diego
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 11. ruj 2026. · NCT07571005A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Escondido
- ACCOMPLISH-2 Research Site, Fountain Valley
- ACCOMPLISH-2 Research Site, La Jolla
- i još 4
U tijeku regrutacijaFaza 3Zdravi dobrovoljci dobrodošli
Od 18 do 79 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07654374A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity
- PAREXEL Glendale/LA EPCU, Glendale
U tijeku regrutacijaFaza 1
Od 18 do 55 godina · Oba spola · Ažurirano 9. ruj 2026. · NCT07566390Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- Headlands Research California, LLC, Escondido
- National Research Institute - Huntington Park, Huntington Park
- Los Angeles Institute for Metabolic Research, Los Angeles
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07770841Effects of Dietary Supplements on Muscle Mass and Function While Using GLP-1 Medication
- UCLA Center for Human Nutrition, Los Angeles
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT07806838A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- NorCal Medical Research, Inc, Greenbrae
- Velocity Clinical Research, Huntington Park, Huntington Park
- Peninsula Research Associates, Rolling Hills Estates
- i još 1
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT06143956A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- First OC Dermatology Research Inc, Fountain Valley
- Center For Dermatology Clinical Research, Inc., Fremont
- Metropolis Dermatology, Los Angeles
- i još 1
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT06857942Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Escondido
- Kailera Clinical Site, La Mesa
- Kailera Clinical Site, Montclair
- i još 3
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Ark Clinical Research- Tustin, Fountain Valley
- Long Beach Clinical Trials Services Inc, Long Beach
- Ark Clinical Research- Long Beach, Long Beach
- i još 6
U tijeku regrutacijaFaza 3
Od 18 do 99 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07684235Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.